메뉴 건너뛰기




Volumn 152, Issue 4, 2016, Pages 482-484

Acute generalized pustular psoriasis treated with the IL-17A antibody secukinumab

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 17; SECUKINUMAB; DERMATOLOGICAL AGENT; IL17A PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

EID: 84963743175     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.4686     Document Type: Article
Times cited : (31)

References (5)
  • 1
    • 84948711592 scopus 로고    scopus 로고
    • Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab
    • Mansouri B, Richards L, Menter A. Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab. Br J Dermatol. 2015;173(1):239-241.
    • (2015) Br J Dermatol , vol.173 , Issue.1 , pp. 239-241
    • Mansouri, B.1    Richards, L.2    Menter, A.3
  • 2
    • 84886875567 scopus 로고    scopus 로고
    • IL36RN mutations in generalized pustular psoriasis: Just the tip of the iceberg?
    • Capon F. IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg? J Invest Dermatol. 2013;133(11):2503-2504.
    • (2013) J Invest Dermatol , vol.133 , Issue.11 , pp. 2503-2504
    • Capon, F.1
  • 3
    • 0023253643 scopus 로고
    • Electronmicroscopic features in generalized pustular psoriasis
    • Heng MC, Heng JA, Allen SG. Electronmicroscopic features in generalized pustular psoriasis. J Invest Dermatol. 1987;89(2):187-191.
    • (1987) J Invest Dermatol , vol.89 , Issue.2 , pp. 187-191
    • Heng, M.C.1    Heng, J.A.2    Allen, S.G.3
  • 4
    • 54249130813 scopus 로고    scopus 로고
    • Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
    • Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008;159(5):1092-1102.
    • (2008) Br J Dermatol , vol.159 , Issue.5 , pp. 1092-1102
    • Nograles, K.E.1    Zaba, L.C.2    Guttman-Yassky, E.3
  • 5
    • 84929630475 scopus 로고    scopus 로고
    • Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis
    • Saeki H, Nakagawa H, Ishii T, et al. Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2015;29(6):1148-1155.
    • (2015) J Eur Acad Dermatol Venereol , vol.29 , Issue.6 , pp. 1148-1155
    • Saeki, H.1    Nakagawa, H.2    Ishii, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.